Fennec Pharmaceuticals FENC
NASDAQ FENC
$10.64 +0.06 (+0.57%)
At close: Nov 11, 2026 · 4:00 PM EST

Fennec Pharmaceuticals (FENC) Current Deferred Revenue (2009 - 2026)

Updated

Fennec Pharmaceuticals' Current Deferred Revenue came in at $3.18 million for Q2 2026, compared with $248,000 a year earlier.

Analysis

Fennec Pharmaceuticals (FENC) Current Deferred Revenue (2009 - 2026) Analysis & Trends

At the end of FY2025, Fennec Pharmaceuticals' Current Deferred Revenue was $248,000, unchanged from FY2024.

  • Going back by year, Current Deferred Revenue was $248,000 in FY2024.
  • The Q2 2026 figure represents the highest quarterly Current Deferred Revenue in data going back to Q1 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Fennec Pharmaceuticals 370.66 Mn 230.50 Mn 17.15 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.18 Mn
Mar 31, 2026 248,000.00
Dec 31, 2025 248,000.00
Sep 30, 2025 248,000.00
Jun 30, 2025 248,000.00
Mar 31, 2025 248,000.00
Dec 31, 2024 248,000.00
Sep 30, 2024 248,000.00
Jun 30, 2024 252,000.00
Mar 31, 2024 252,000.00
Sep 30, 2009 207,000.00
Jun 30, 2009 545,000.00
Mar 31, 2009 546,000.00
API Access

Fennec Pharmaceuticals Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=FENC&period=max&api_key=YOUR_API_KEY